Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/1999

01-04-1999 | ORIGINAL ARTICLE

Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients

Authors: M. E. E. Sabbioni, Monica Castiglione, Christoph Hürny, Hans-Peter Siegrist, Marisa Bacchi, Jürg Bernhard, Beat Thürlimann, Hervé Bonnefoi, Lucien Perey, Aron Goldhirsch, Hans-Jörg Senn

Published in: Supportive Care in Cancer | Issue 3/1999

Login to get access
Metadata
Title
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
Authors
M. E. E. Sabbioni
Monica Castiglione
Christoph Hürny
Hans-Peter Siegrist
Marisa Bacchi
Jürg Bernhard
Beat Thürlimann
Hervé Bonnefoi
Lucien Perey
Aron Goldhirsch
Hans-Jörg Senn
Publication date
01-04-1999
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/1999
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050245

Other articles of this Issue 3/1999

Supportive Care in Cancer 3/1999 Go to the issue

OriginalPaper

Supportive Care News

ORIGINAL ARTICLE

Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS)

SPECIAL ARTICLE

Breaking bad news to patients: physicians' perceptions of the process

ORIGINAL ARTICLE

The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients

OriginalPaper

LETTER TO THE EDITOR

EDITORIAL

Psychosocial research in supportive care: focusing the health care system
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits